InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+44.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Becker Daniel J., Director. Director active across 2 companies, notably Day One Biopharmaceuticals, Inc.. In total, 5 filings have been published. Split: 3 buys · 1 sell. Total volume traded: €180k. History available since 1 June 2021. The latest transaction was disclosed on 17 July 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
2,999 sharesCommon StockSEC:0001962918-25-000052:0
1 shares@ US$6.860.0% of flowCommon StockSEC:0001962918-24-000099:0
3,000 shares@ US$18.00100.0% of flowCommon StockSEC:0001209191-23-028874:0
Ideal exit: 3 Feb 2024 (T+270)
5,000 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-21-037023
Ideal exit: 26 Feb 2022 (T+270)
5,000 shares@ US$16.000.0068% mcap50.0% of flowCommon StockSEC:0001209191-21-037023:0
Ideal exit: 26 Feb 2022 (T+270)
5 of 5 declarations
About Becker Daniel J.
Daniel J. Becker is a Board Member at Day One Biopharmaceuticals, Inc. He plays a key role in the governance of the company, providing strategic advice and oversight of operations. His experience in the biopharmaceutical sector allows him to contribute to the innovation and growth of Day One. As a board member, he participates in critical decision-making for the company's future.
